November 20 |
Review of the Evidence
|
|
|
Moderator: Coleen Boyle |
|
|
|
|
8:00 a.m. |
Welcome and Introductions |
Coleen Boyle and Preston Campbell |
|
|
|
8:15 a.m. |
Criteria for newborn screening |
Brad Therrell |
|
|
|
|
|
|
8:30 a.m. |
Overview of evidence-based decision-making for screening interventions |
Mark Helfand |
|
|
|
8:45 a.m. |
Panel discussion on criteria for evidence of benefits |
Tom Locke, Jeff Botkin, George Cunningham |
|
|
|
9:15 a.m. |
Epidemiology and Natural History of CF |
Preston Campbell and Frank Accurso |
|
|
|
10:00 a.m. |
Break
|
|
|
Moderator: Preston Campbell |
|
|
|
|
10:15 a.m. |
Overview of published evidence on outcomes with early detection
|
|
Wisconsin clinical trial
|
Phil Farrell |
|
Observational data from US |
Margaret Rosenfeld |
|
|
|
11:15 a.m. |
International Experience
|
|
|
Published evidence from Europe
|
Jeannette Dankert |
|
Recent UK experience
|
Anil Mehta |
|
New pulmonary outcome data and early therapy for pancreatic deficiency in Australia
|
Karen McKay |
|
Opportunities for early intervention for Pseudomonas aeruginosa |
Niels Hoiby |
|
|
|
12:15 p.m. |
Working Lunch (Provided) |
|
|
|
|
|
Moderator: Robert Wilmott |
|
|
|
|
1:00 p.m. |
New data – US
|
|
|
Survival advantage
|
Hui-Chuan Lai |
|
Cognitive outcomes and quality of life
|
Rebecca Koscik |
1:30 p.m. |
Panel and discussion– Grading the Evidence |
Mark Helfand, Peter Briss, Muin Khoury, Frank Desposito
|
|
Moderator: Ben Wilfond |
|
|
|
|
2:30 p.m. |
Overview of Risks
|
|
|
Potential harms
|
Norman Fost |
|
False positives and psychosocial risks
|
Jeannette Dankert |
|
Delayed diagnosis and the family perspective |
Martin Kharrazi |
|
|
|
3:15 p.m. |
Break |
|
|
|
|
3:45 p.m. |
Weighing Risks and Benefits: Screening justification and balancing harm
|
|
Discussion panel
|
Richard Parad, Kenneth Fink, Lainie Ross |
4:30 p.m. |
Summary and integration of presented information, discussion of conclusions |
Coleen Boyle |
|
|
|
5:30 p.m. |
Adjourn |
|
|
|
|
November 21 |
Screening, Diagnosis and Follow-up: The Role They Play in Decision Making
|
|
Moderator: Harry Hannon |
|
|
|
|
7:50 a.m. |
Newborn Screening: The System |
Brad Therrell |
|
|
|
8:10 a.m. |
Planning Challenges for a Successful Screening Program |
Anne Comeau |
|
|
|
8:30 a.m. |
Screening Issues
|
|
|
Screening models
|
Ben Wilfond, overview
|
|
Wisconsin
New York
Pediatrix
Colorado
|
Gary Hoffman
Ken Pass
Dennis Freer
Marci Sontag |
|
Topics: IRT, DNA mutations, false positives, false negatives, carriers etc.
|
|
Performance evaluation of laboratories |
Joanne Mei |
|
|
|
10:00 a.m. |
Break
|
|
|
Moderator: Michele Puryear |
|
|
|
|
10:15 a.m. |
Informed Consent
|
|
|
How important is informed consent?
|
Ellen Wright Clayton
|
|
Implementation of informed consent in a newborn screening program
|
Jean-Louis Dhondt |
|
|
|
10:45 a.m. |
Diagnostics and Sweat Testing Referrals
|
|
Wisconsin's approach |
Mike Rock
|
|
Massachusetts' approach |
Richard Parad |
|
|
|
11:15 a.m. |
Linking with CF Centers for care of diagnosed infants
|
|
Massachusetts Experience |
Hank Dorkin
|
|
New York experience |
Robert Kaslovsky |
|
|
|
11:45 a.m. |
Lunch (Provided) |
|
|
Moderator: George Cunningham |
|
|
|
|
12:30 p.m. |
Rapporteur
|
George Cunningham (CA)
|
|
Panel – Implications for state programs considering screening for CF |
Pam King (OK), Jerry McClure (MS), Kathy Tomashitis (SC) |
|
|
|
1:30 p.m. |
Communication with parents and providers, including challenge of genetic counseling – issues and protocols
|
|
Communication perspective |
James Dillard
|
|
Massachusetts experience |
Anne Comeau |
|
|
|
2:00 p.m. |
Costs of screening |
|
|
Wisconsin experience |
Phil Farrell
|
|
Discussion |
Scott Grosse |
|
|
|
2:30 p.m. |
Break |
|
|
|
|
3:00 p.m. |
Tying it Together: Weighing the Evidence for a Public Health |
Response to Cystic Fibrosis – Jeff Botkin |
|
|
|
3:45 p.m. |
Closing remarks |
Coleen Boyle & Preston Campbell |
|
|
|
4:00 p.m. |
Adjourn |
|
|
|
|